Relationship between cigarettes per day and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline model evaluation. by Erfan Tasdighi (9144667)

Subjects:

Association between the number of cigarettes per day with cardiovascular outcomes among current cigarette users. by Erfan Tasdighi (9144667)

Subjects:

Cessation duration and pack-years concurrent effect on the hazard ratio (HR) for cardiovascular and mortality outcomes. by Erfan Tasdighi (9144667)

Subjects:

Association between smoking Status and Incidence of cardiovascular and mortality outcomes among women. by Erfan Tasdighi (9144667)

Subjects:

Flow chart of experimental protocol. by Eun-Seon Yang (19751340)

Subjects:

General characteristics and resting vital signs of the participants. by Eun-Seon Yang (19751340)

Subjects:

A representative participant performing a Valsalva maneuver while checking the real-time respiratory pressure indicator. by Eun-Seon Yang (19751340)

Subjects:

Biosignals acquisition protocols in pre and post VM. by Eun-Seon Yang (19751340)

Subjects:

A representative ultrasound axis image. by Eun-Seon Yang (19751340)

Subjects:

Vascular dynamic changes caused by VM performance. by Eun-Seon Yang (19751340)

Subjects:

Comparison of the correlations of PWV and stiffness with variables. by Eun-Seon Yang (19751340)

Subjects:

Socio-demographic and medical characteristics of patients with liver cancer. by Ayana Ablayeva (22103708)

Subjects:

Data cleaning and preparation algorithm. by Ayana Ablayeva (22103708)

Subjects:

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Association of <i>Shigella</i> infections with EE biomarker concentration over time. by Haley A. Liakakos (21445884)

Subjects:

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

Subjects:

Associations between <i>Shigella</i> infections and EE biomarker concentrations from time of index subclinical <i>Shigella</i> detection through 6-months post-detection, stratified... by Haley A. Liakakos (21445884)

Subjects:

Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects: